Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.8K Hold
597
0.04% 46
2025
Q4
$62.8K Hold
597
0.03% 41
2025
Q3
$50.1K Hold
597
0.03% 46
2025
Q2
$47.3K Sell
597
-279
-32% -$22.2K 0.04% 41
2025
Q1
$78.6K Buy
876
+79
+10% +$7.38K 0.06% 36
2024
Q4
$79.3K Buy
797
+200
+34% +$20.6K 0.06% 28
2024
Q3
$67.8K Hold
597
0.05% 25
2024
Q2
$73.9K Hold
597
0.06% 22
2024
Q1
$78.8K Hold
597
0.07% 20
2023
Q4
$65.1K Hold
597
0.08% 21
2023
Q3
$61.5K Hold
597
0.11% 21
2023
Q2
$68.9K Hold
597
0.17% 17
2023
Q1
$63.5K Hold
597
0.26% 18
2022
Q4
$66.2K Hold
597
0.11% 19
2022
Q3
$51K Hold
597
0.09% 22
2022
Q2
$54K Hold
597
0.14% 23
2022
Q1
$48K Hold
597
0.04% 24
2021
Q4
$45K Buy
+597
New +$47.5K 0.03% 36
2021
Q1
Sell
-626
Closed -$48K 102
2020
Q4
$48K Buy
+626
New +$47.9K 0.04% 46

Other funds holding MRK

IFS Advisors's MRK Position: Q1 2026 in Review

IFS Advisors held its Merck (MRK) position steady in Q1 2026 at 597 shares worth $71.8K. The position accounts for 0.04% of the portfolio, ranked #46.

IFS Advisors first reported a position in MRK in Q4 2020 and has held it in 19 quarters since. The position peaked at $79.3K in Q4 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • IFS Advisors held 597 shares of Merck worth $71.8K as of Q1 2026.
  • IFS Advisors left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.04% of IFS Advisors's portfolio in Q1 2026, its #46 holding.
  • IFS Advisors first reported a position in Merck in Q4 2020 and has held it in 19 quarters since.
  • IFS Advisors's Merck position peaked at $79.3K in Q4 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on IFS Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.